Literature DB >> 11986329

Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen.

Anke Rattenholl1, William N Pappano, Manuel Koch, Douglas R Keene, Karl E Kadler, Takako Sasaki, Rupert Timpl, Robert E Burgeson, Daniel S Greenspan, Leena Bruckner-Tuderman.   

Abstract

Collagen VII is the major structural component of the anchoring fibrils at the dermal-epidermal junction in the skin. It is secreted by keratinocytes as a precursor, procollagen VII, and processed into mature collagen during polymerization of the anchoring fibrils. We show that bone morphogenetic protein-1 (BMP-1), which exhibits procollagen C-proteinase activity, cleaves the C-terminal propeptide from human procollagen VII. The cleavage occurs at the BMP-1 consensus cleavage site SYAA/DTAG within the NC-2 domain. Mammalian tolloid-like (mTLL)-1 and -2, two other proteases of the astacin enzyme family, were able to process procollagen VII at the same site in vitro. Immunohistochemical and genetic evidence supported the involvement of these enzymes in cleaving type VII procollagen in vivo. Both BMP-1 and mTLL-1 are expressed in the skin and in cultured cutaneous cells. A naturally occurring deletion in the human COL7A1 gene, 8523del14, which is associated with dystrophic epidermolysis bullosa and eliminates the BMP-1 consensus sequence, abolished processing of procollagen VII, and in mutant skin procollagen VII accumulated at the dermal-epidermal junction. On the other hand, deficiency of BMP-1 in the skin of knockout mouse embryos did not prevent processing of procollagen VII to mature collagen, suggesting that mTLL-1 and/or mTLL-2 can substitute for BMP-1 in the processing of procollagen VII in situ.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986329     DOI: 10.1074/jbc.M203247200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Metalloproteinases in Drosophila to humans that are central players in developmental processes.

Authors:  Alison Muir; Daniel S Greenspan
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

2.  Can type VII collagen injections cure dystrophic epidermolysis bullosa?

Authors:  Leena Bruckner-Tuderman
Journal:  Mol Ther       Date:  2009-01       Impact factor: 11.454

3.  Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils.

Authors:  Daniela Villone; Anja Fritsch; Manuel Koch; Leena Bruckner-Tuderman; Uwe Hansen; Peter Bruckner
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

4.  Dominant-negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII.

Authors:  Anja Fritsch; Sashko Spassov; Susanne Elfert; Andreas Schlosser; Yannick Gache; Guerrino Meneguzzi; Leena Bruckner-Tuderman
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

Review 5.  The bone morphogenetic protein 1/Tolloid-like metalloproteinases.

Authors:  Delana R Hopkins; Sunduz Keles; Daniel S Greenspan
Journal:  Matrix Biol       Date:  2007-05-18       Impact factor: 11.583

6.  C-terminal proteolysis of the collagen VI α3 chain by BMP-1 and proprotein convertase(s) releases endotrophin in fragments of different sizes.

Authors:  Stefanie Elisabeth Heumüller; Maya Talantikite; Manon Napoli; Jean Armengaud; Matthias Mörgelin; Ursula Hartmann; Gerhard Sengle; Mats Paulsson; Catherine Moali; Raimund Wagener
Journal:  J Biol Chem       Date:  2019-07-25       Impact factor: 5.157

7.  Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK.

Authors:  Sanjay Kansra; Stefan W Stoll; Jessica L Johnson; James T Elder
Journal:  Mol Biol Cell       Date:  2004-07-14       Impact factor: 4.138

8.  A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.

Authors:  Anja Fritsch; Stefan Loeckermann; Johannes S Kern; Attila Braun; Michael R Bösl; Thorsten A Bley; Hauke Schumann; Dominik von Elverfeldt; Dominik Paul; Miriam Erlacher; Dirk Berens von Rautenfeld; Ingrid Hausser; Reinhard Fässler; Leena Bruckner-Tuderman
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  High-throughput T7 LIC vector for introducing C-terminal poly-histidine tags with variable lengths without extra sequences.

Authors:  Jonas Lee; Sung-Hou Kim
Journal:  Protein Expr Purif       Date:  2008-09-14       Impact factor: 1.650

10.  Timing-dependent actions of NGF required for cell differentiation.

Authors:  Jaehoon Chung; Hiroyuki Kubota; Yu-ichi Ozaki; Shinsuke Uda; Shinya Kuroda
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.